Almost three million dollars to the former first lady's campaign paid by her sworn enemies of yesterday who, this time, sensed her conquest of the White House. When she was first lady and her husband Bill put her in charge of engineering health care reform, drug and insurance companies mounted a furious and costly campaign to derail her, and they succeeded. Now, Hillary Clinton is their favorite candidate for the White House, in an electoral campaign in which health care reform is one of the qualifying points. Pharmaceuticals and insurers traditional supporters of the Republicans, from whom they feel more "protected" – have so far poured into Hillary's campaign coffers 2.7 million dollars and their reversal in the face is so to speak perfected by the fact that immediately after her there is the other Democratic candidate with the possibility of obtaining the nomination, Barak Obama with 2.2 million, followed only by the Republicans Mitt Romney (1.6 million) and Rudolph Giuliani with 1.4 million. At the moment this is the most relevant novelty that this very long campaign to decide who should take over from George Bush has produced. The first possible explanation we hear is that the powerful American pharmaceutical and insurance companies have seriously "sniffed out" the possibility that Republican candidates in 2008 will find themselves paying the price for Bush's growing unpopularity and that they have therefore concluded that it is better to be on the winning side, after the vote has taken place exactly one year from now. "It's a defensive measure," says industry expert Phillip Blando. “Healthcare is this time the main internal policy issue that the next president will have to deal with and everyone wants to sit at the decision-making table when they are made. This does not mean, of course, that suddenly love blossomed between the drug companies and Hillary Clinton. Some of your electoral promises still don't go down well with companies, such as the one that you - if you go to the White House - will oblige them to offer a health coverage plan at a reasonable price and valid for anyone; or that of allowing the importation of medicines from Canada, whose price is much lower (currently the import is prohibited, officially because the American health authorities must first "examine" those drugs, as if they came from a country that cannot be trusted); or even that of ensuring that Medicare, i.e. the federal pension assistance organization, can negotiate the price of drugs with the companies, in order to solicit competition between them, which is currently not possible because the price of drugs is set by the government, which established it with the "collaboration" of the companies themselves. But however unpleasant these "threatening" positions professed by Hillary Clinton, Barak Obama and even the third Democratic candidate John Edward may be to their ears, the companies have preferred to make the best of a bad situation, playing all his cards on the possibility that, as his "supporters", the future democratic president (if he will) still agree to consult them when the time comes to enact the reform, hoping to wrest some corrections. There is also c
